Voxvoganan trihydrochloride

• CAT Number: I041239
• Molecular Formula: C43H72Cl3N11O3
• Molecular Weight: 897.46
• Purity: ≥95%
• Synonyms: (2S)-2-amino-5-(diaminomethylideneamino)-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(2-phenylethylamino)pentan-2-yl]amino]-1-oxo-3-(2,5,7-tritert-butyl-1H-indol-3-yl)propan-2-yl]pentanamide;trihydrochloride
• InChI: InChI=1S/C43H69N11O3.3ClH/c1-41(2,3)27-23-28-29(35(43(7,8)9)54-34(28)30(24-27)42(4,5)6)25-33(53-36(55)31(44)17-13-20-50-39(45)46)38(57)52-32(18-14-21-51-40(47)48)37(56)49-22-19-26-15-11-10-12-16-26;;;/h10-12,15-16,23-24,31-33,54H,13-14,17-22,25,44H2,1-9H3,(H,49,56)(H,52,57)(H,53,55)(H4,45,46,50)(H4,47,48,51);3*1H/t31-,32-,33-;;;/m0.../s1
• InChIKey: KXMSCJYCDUWIMI-RZQNRPNSSA-N
• SMILES: CC(C)(C)C1=CC2=C(C(=C1)C(C)(C)C)NC(=C2C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCC3=CC=CC=C3)NC(=O)[C@H](CCCN=C(N)N)N)C(C)(C)C.Cl.Cl.Cl

Voxvoganan trihydrochloride（Cat No.:I041239）is a chemical compound under investigation for its potential therapeutic applications, particularly in the treatment of neurodegenerative diseases and cancer. It acts by modulating specific cellular pathways that may influence immune response, apoptosis, and cell proliferation. The trihydrochloride form of Voxvoganan enhances its solubility and stability, making it suitable for in vitro and in vivo studies. Researchers are exploring its efficacy in addressing conditions where dysregulated cell growth or immune system dysfunction is involved. Voxvoganan trihydrochloride is being studied for its potential as a novel therapeutic agent in clinical settings.